Veyong pharma participatur in 89th Sina International Pharmaceutical API Exhibition

Octobris XVIII, in Sina 89th InternationalPharmaceutical APIPre se ferre erat grandem tenuit ad Nanjing Internationalis Expo Center. Li Jianjie, Generalis Procurator ofVeyong Pharma, Li Jieqing, Deputy Generalis Procurator et Generalis procurator de Internationalis Marketing Center, et Technology Research et Development of Limin tenementum Group Nie Fengqiu et Director of Synthesis R & D Landoration of the Central Research Principium et Zhongfang et procurator et Marketing ManagerVeyong PHARMACEUTICAL et aliis participatur in conventu, congregat cum multis outstanding societates ad innovate, cooperari et invenietis vitale!

Per se ferre, sol Jingquan, Director of Research Institute of Limin Holdings Technology R & D centrum, visited inVeyong PHARMACEUTICICUS Pre se ferre area, visitedVeyong Pharmaceutical`S API series products, et expressit in gratiam omnibus qui participatur in se ferre. Comitante a coetus populi, D. sol visited a numerus of pharmaceutical coetibus et societates ut livzon Group, thesun pharmaceuticals, borui pharmaceuticals et progressionem et in communem, ut novam et in comitatu`S Next Key Product Research et Development consilia, technica Research Projects et productum supporting projects cumNovusVeyong. Necesse est ut plenum usum coetus`Suadet, qui coordinationem, et promovere omnia facies opus. Et lenis exsequendam uber innovation, technology investigationis et progressionem, gubernator probatio, magna-scale productio et technica transformationem projects providere et longa-terminus in futurum.

Tertio die exhibitionis erant adhuc turbae populi. Et visitatores erant valde studere et vivi. InVeyong Pharma Pre se ferre praetorium attracted multas domesticis et aliena customers ut subsisto inquiri et communicare. Cum autem professionalism de Sales quadrigis, ut studio et patienter introduced societatis ad customers unum per unum. Product Quality et R & D commoda nos quoque habere in-profundum intellectus mos necessitatibus, de quibus ad current foro statu, et lucrata alia coetus novi amici!

Freti in coetus scriptor commoda:Veyong PHARMACEUTICAL habet semper adhaerendum est progressionem belli ex integrating rudis materiae etpraeparataUt cope cum Market provocationes et consequi stabilis et diu-term development.